IN THE MANAGEMENT OF TYPE 2 DIABETES^*1

THE POWER TO
ACCOMPLISH
MORE

MULTIPLE BENEFITS.* PROVEN PROTECTION.^†

What do you think of the latest ESC Guidelines on treatment for HF?

06/02/2024 | Author: Boehringer Ingelheim

Document ID: PC-MY-103448

RELATED CONTENT